Endocrine Abstracts

Primary Aldosteronism (PA) is the commonest secondary cause of hypertension. Multiple studies worldwide suggest a prevalence of approximately 10% in an unselected hypertensive cohort and up to 20% in resistant hypertension. This does not correlate with real world experience and PA remains a significantly under-recognised condition. There is a myth that the biochemical diagnosis of PA is complex and requires significant alterations to drug therapy and very specific diagnostic sampling conditions. In this short presentation, I hope to alter this perception and demonstrate to the audience that screening for PA should be simple and possible in any secondary care setting. Subsequent confirmatory testing is not always required but the most straightforward options to confirm the diagnosis will be discussed in detail. The aim is to lower the diagnostic threshold and improve treatment and cure of this common condition.